about
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote ca...
Read More
6.23
-0.06
(-0.95%)
3.8M
XNAS Volume
XNAS 30 Jul, 2025 4:18 PM (EDT)
Board Meeting
The next board meeting for Verastem Inc is on 08 Aug 2025 for the purpose of Verastem Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Verastem Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..